|
EXOG expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.777790E-02 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
9.046100E-02 |
| Normal-vs-Stage2 |
9.168400E-02 |
| Normal-vs-Stage3 |
2.032300E-02 |
| Normal-vs-Stage4 |
4.447500E-02 |
| Stage1-vs-Stage2 |
5.350600E-01 |
| Stage1-vs-Stage3 |
2.837800E-01 |
| Stage1-vs-Stage4 |
3.120200E-01 |
| Stage2-vs-Stage3 |
8.681800E-01 |
| Stage2-vs-Stage4 |
8.291000E-01 |
| Stage3-vs-Stage4 |
9.287000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.782300E-03 |
| Normal-vs-AfricanAmerican |
4.088800E-01 |
| Normal-vs-Asian |
3.282600E-01 |
| Caucasian-vs-AfricanAmerican |
1.127620E-02 |
| Caucasian-vs-Asian |
1.498440E-01 |
| AfricanAmerican-vs-Asian |
4.040400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
9.399200E-03 |
| Normal-vs-Female |
1.413370E-01 |
| Male-vs-Female |
2.264600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
9.728600E-01 |
| Normal-vs-Age(41-60Yrs) |
2.090800E-01 |
| Normal-vs-Age(61-80Yrs) |
2.578900E-03 |
| Normal-vs-Age(81-100Yrs) |
9.935400E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
5.376000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.086560E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
6.751800E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
4.263700E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.428600E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
4.855400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
5.613800E-01 |
| Normal-vs-Grade 2 |
2.010600E-01 |
| Normal-vs-Grade 3 |
3.041700E-03 |
| Normal-vs-Grade 4 |
3.051500E-02 |
| Grade 1-vs-Grade 2 |
2.459200E-01 |
| Grade 1-vs-Grade 3 |
4.711500E-02 |
| Grade 1-vs-Grade 4 |
1.110990E-01 |
| Grade 2-vs-Grade 3 |
5.068100E-02 |
| Grade 2-vs-Grade 4 |
1.514960E-01 |
| Grade 3-vs-Grade 4 |
9.076600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
7.135200E-03 |
| Normal-vs-ccB subtype |
4.440000E-01 |
| ccA subtype-vs-ccB subtype |
5.368000E-02 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.431610E-01 |
| Normal-vs-N1 |
1.035200E-01 |
| N0-vs-N1 |
4.790400E-01 |
|
|
